These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7888983)

  • 21. Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers.
    Naranjo CA; Sellers EM
    Recent Dev Alcohol; 1989; 7():255-66. PubMed ID: 2522667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brief intervention for medical inpatients with unhealthy alcohol use: a randomized, controlled trial.
    Saitz R; Palfai TP; Cheng DM; Horton NJ; Freedner N; Dukes K; Kraemer KL; Roberts MS; Guerriero RT; Samet JH
    Ann Intern Med; 2007 Feb; 146(3):167-76. PubMed ID: 17283347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief physician advice for alcohol problems in older adults: a randomized community-based trial.
    Fleming MF; Manwell LB; Barry KL; Adams W; Stauffacher EA
    J Fam Pract; 1999 May; 48(5):378-84. PubMed ID: 10334615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between central serotonergic neurotransmission and reduction in alcohol intake by citalopram.
    Berggren U; Eriksson M; Fahlke C; Balldin J
    Drug Alcohol Depend; 2001 Aug; 63(3):263-7. PubMed ID: 11418230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.
    Naranjo CA; Kadlec KE; Sanhueza P; Woodley-Remus D; Sellers EM
    Clin Pharmacol Ther; 1990 Apr; 47(4):490-8. PubMed ID: 2328557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citalopram as an inhibitor of voluntary ethanol intake in the male rat.
    Hedlund L; Wahlström G
    Alcohol; 1998 Nov; 16(4):295-303. PubMed ID: 9818981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin uptake blockers and the treatment of alcoholism.
    Gorelick DA
    Recent Dev Alcohol; 1989; 7():267-81. PubMed ID: 2648494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of cognitive-behavioural therapy for coexisting depression and alcohol problems: short-term outcome.
    Baker AL; Kavanagh DJ; Kay-Lambkin FJ; Hunt SA; Lewin TJ; Carr VJ; Connolly J
    Addiction; 2010 Jan; 105(1):87-99. PubMed ID: 19919594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal brain matter differences associated with lifetime alcohol intake and visual attention in male but not in female non-alcohol-dependent drinkers.
    de Bruin EA; Hulshoff Pol HE; Schnack HG; Janssen J; Bijl S; Evans AC; Kenemans JL; Kahn RS; Verbaten MN
    Neuroimage; 2005 Jun; 26(2):536-45. PubMed ID: 15907310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social network moderators of naltrexone and behavioral treatment effects on heavy drinking in the COMBINE study.
    Worley MJ; Witkiewitz K; Brown SA; Kivlahan DR; Longabaugh R
    Alcohol Clin Exp Res; 2015 Jan; 39(1):93-100. PubMed ID: 25623409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drinking goal selection in behavioral self-management treatment of chronic alcoholics.
    Hodgins DC; Leigh G; Milne R; Gerrish R
    Addict Behav; 1997; 22(2):247-55. PubMed ID: 9113218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results.
    Wong WM; Hasemann S; Schwarz M; Zill P; Koller G; Soyka M; Preuss UW
    Pharmacopsychiatry; 2008 Mar; 41(2):72-8. PubMed ID: 18311688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
    Roy-Byrne PP; Pages KP; Russo JE; Jaffe C; Blume AW; Kingsley E; Cowley DS; Ries RK
    J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drinking experiences in three populations of male drinkers.
    Connors GJ; O'Farrell TJ; Cutter HS
    J Addict Dis; 1991; 10(3):25-33. PubMed ID: 1932150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.
    Adamson SJ; Sellman JD; Foulds JA; Frampton CM; Deering D; Dunn A; Berks J; Nixon L; Cape G
    J Clin Psychopharmacol; 2015 Apr; 35(2):143-9. PubMed ID: 25679122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buspirone in the treatment of alcoholic patients.
    Bruno F
    Psychopathology; 1989; 22 Suppl 1():49-59. PubMed ID: 2657838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.